Baxter International Total Liab Over Time
| BAX Stock | USD 33.42 0.21 0.63% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Baxter International Performance and Baxter International Correlation. Baxter |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baxter International. If investors know Baxter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baxter International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 1.16 | Earnings Share 0.25 | Revenue Per Share 29.635 | Quarterly Revenue Growth 0.038 |
The market value of Baxter International is measured differently than its book value, which is the value of Baxter that is recorded on the company's balance sheet. Investors also form their own opinion of Baxter International's value that differs from its market value or its book value, called intrinsic value, which is Baxter International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baxter International's market value can be influenced by many factors that don't directly affect Baxter International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baxter International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baxter International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baxter International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Liab Analysis
Compare Baxter International and related stocks such as Embecta Corp, West Pharmaceutical, and ResMed Inc Total Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBC | 126 M | 126 M | 126 M | 126 M | 126 M | 126 M | 126 M | 126 M | 126 M | 166 M | 194 M | 2 B | 2 B | 2.3 B | 1.2 B |
| WST | 59.5 M | 744.2 M | 835.1 M | 765.2 M | 336.7 M | 298.2 M | 228.6 M | 197 M | 196.1 M | 768.2 M | 939.3 M | 978.4 M | 931.9 M | 948.5 M | 995.9 M |
| RMD | 2.3 M | 530.2 M | 600.2 M | 602.7 M | 597 M | 1.6 B | 1.5 B | 1 B | 2 B | 2.1 B | 1.8 B | 1.7 B | 2.6 B | 2 B | 2.1 B |
| COO | 341.5 M | 728.2 M | 713.8 M | 1.9 B | 1.8 B | 1.8 B | 1.7 B | 2.8 B | 2.6 B | 2.9 B | 2.7 B | 4.3 B | 4.1 B | 4.7 B | 5 B |
| TFX | 52.6 M | 1.9 B | 2 B | 2.3 B | 2.1 B | 1.9 B | 1.8 B | 3.8 B | 3.7 B | 3.3 B | 3.8 B | 3.1 B | 2.9 B | 3.1 B | 1.6 B |
| BDX | 559.8 M | 7.2 B | 7.1 B | 7.4 B | 19.7 B | 18 B | 24.8 B | 32.9 B | 30.7 B | 30.2 B | 30.2 B | 27.6 B | 27 B | 31.4 B | 32.9 B |
| HOLX | 5.3 M | 7.5 B | 7.1 B | 6.4 B | 5.6 B | 5.2 B | 5.2 B | 4.8 B | 4.3 B | 4.5 B | 4.7 B | 4.2 B | 4.1 B | 4 B | 2.5 B |
| MMSI | 600 K | 89.9 M | 323.7 M | 322.6 M | 311.9 M | 312.6 M | 444.6 M | 435.5 M | 687.2 M | 807.4 M | 705.8 M | 608.5 M | 519.6 M | 1.1 B | 1.2 B |
| ICUI | 2.4 M | 40.5 M | 37.7 M | 34.9 M | 32.9 M | 47 M | 44.5 M | 298.7 M | 321.7 M | 315.1 M | 261.4 M | 264.7 M | 2.4 B | 2.3 B | 2.4 B |
| NVST | 998.2 M | 998.2 M | 998.2 M | 998.2 M | 998.2 M | 998.2 M | 998.2 M | 998.2 M | 1 B | 2.6 B | 3.2 B | 2.5 B | 2.4 B | 2.4 B | 2.4 B |
| ALC | 3 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.7 B | 4.4 B | 4.4 B | 8.4 B | 8.8 B | 8.7 B | 9.5 B | 9 B | 6.5 B |
Baxter International and related stocks such as Embecta Corp, West Pharmaceutical, and ResMed Inc Total Liab description
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.My Equities
My Current Equities and Potential Positions
| Baxter International | BAX |
| Classification | Medical Equipment |
| Location | Illinois; U.S.A |
| Exchange | New York Stock Exchange |
USD 33.42
Additional Tools for Baxter Stock Analysis
When running Baxter International's price analysis, check to measure Baxter International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baxter International is operating at the current time. Most of Baxter International's value examination focuses on studying past and present price action to predict the probability of Baxter International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baxter International's price. Additionally, you may evaluate how the addition of Baxter International to your portfolios can decrease your overall portfolio volatility.